Vitamin K and Bone Turnover in Postmenopausal Women

PHASE3CompletedINTERVENTIONAL

Enrollment

375

Participants

Timeline

Start Date

September 30, 2000

Study Completion Date

October 31, 2004

Conditions

Osteoporosis

Interventions

DRUG

phylloquinone (K1)

DRUG

menatetranone (MK4)

Trial Locations (1)

University of Wisconsin Osteoporosis Clinical Research Prog., Madison

All Listed Sponsors

collaborator

Eisai Co., Ltd.

INDUSTRY

lead

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

NCT00062595 - Vitamin K and Bone Turnover in Postmenopausal Women | Biotech Hunter | Biotech Hunter